Coronavirus — I stopped my allergy vaccine treatment — Was I more exposed to the Coronavirus?

Reading time: 12 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Coronavirus — I stopped my allergy vaccine treatment — Was I more exposed to the Coronavirus?

Clinical Summary and Overview

In the realm of allergic and immune-mediated diseases, the topic Coronavirus It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Coronavirus — I stopped my allergy vaccine treatment — Am I more exposed to the Coronavirus?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Coronavirus — I stopped my allergy vaccine treatment — Was I more exposed to the Coronavirus?

Impact of the Allergy Vaccine Interruption and its Relationship to the Coronavirus

During the COVID-19 pandemic, many doubts arose regarding the continuation of ongoing medical treatments, such as allergen-specific immunotherapy (popularly known as allergy shots). Fear of contagion led many patients to abruptly interrupt their treatments, generating legitimate concerns about a supposed increased vulnerability to the coronavirus and other respiratory infections.

Allergy vaccine treatment has a standard recommended duration ranging from three to five years. This period is crucial for modulating the immune system, stimulating regulatory memory cells that keep the patient free from chronic inflammatory processes. If treatment is interrupted before the minimum recommended time—especially if the patient still has active symptoms—it is likely that adequate immunological memory has not yet been fully established.

Maintaining control of allergic respiratory diseases is of utmost importance. Uncontrolled allergic inflammatory conditions increase local blood flow and the expression of adhesion molecules in the mucous membranes. These proteins can facilitate the penetration of viral agents into the body, which theoretically predisposes the individual to complications from viral infections in general, including influenza, colds, and related respiratory infections.

Given the interruption of treatment and the reappearance of symptoms, the most prudent course of action is to resume specialized medical care as soon as possible. Adjustments to the treatment regimen should be individualized based on the patient's clinical history and medical records.

General Guidelines for Prevention and Immunization

  • Resumption of Immunotherapy: Talk to your doctor to reassess your current clinical condition and safely resume allergy vaccinations.
  • Vaccination against Flu and Pneumonia: It is recommended to administer the influenza vaccines available at health centers (trivalent or tetravalent), respecting the 30-day interval in relation to pneumococcal vaccines (such as Pneumo 13 and Pneumo 23), in addition to the appropriate bacterial vaccine as prescribed.
  • Groups of risk: Patients who belong to vulnerable groups — such as those with severe asthma, diabetes, high blood pressure, or other chronic conditions — should strictly adhere to the supplementary vaccination schedule recommended by their doctor.

Important note: This content is strictly educational and informative, based on the guidelines of the Brazil Without Allergies Project (Dr. Marcello Bossois). It does not in any way replace consultation, diagnosis, and individualized evaluation with a specialist physician.

Developments in Evidence-Based Medicine: Vaccine Immunology and Allergen-Specific Immunotherapy

In Evidence-Based Medicine (WHO, EAACI and ASBAI), two complementary strategies for modulating the immune system are distinguished: (1) the preventive anti-infectious immunizing vaccines, which stimulate humoral (neutralizing IgG/IgA antibodies) and cellular (memory T lymphocytes) adaptive immunity against viral and bacterial pathogens; and (2) a Allergen-specific immunotherapy (allergy vaccines), the only treatment that modifies the natural history of IgE-mediated allergic diseases. The controlled and progressive administration of standardized allergenic extracts promotes an immunological shift from the Th2 to the Th1 profile, inducing the expansion of regulatory T lymphocytes (CD4)+CD25+FOXP3+) producers of IL-10 and TGF-β and stimulates the synthesis of IgG4 subclass blocking antibodies, thus sustainably reducing clinical hyper-reactivity and the need for symptomatic drugs.

💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Safe Immunization, Immune Response, and Protection of the Allergic Patient

Vaccine Mechanisms, Excipients, and Assessment of Immune Competence

In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.

Integration between Vaccination Schedule, Allergy Tests and Baseline Monitoring

Individualized assessment by an allergist and immunologist correlates laboratory tests of cellular and humoral immunity with the patient's actual clinical history. Combining the allergy test well indicated for preventive monitoring — including allergy vaccine In cases of atopic dermatitis, and with immunostimulant vaccines when applicable, broad, safe protection based on scientific evidence is guaranteed.

Difference between Exaggerated Local Reaction, Strophulus, and Anaphylaxis

Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.

Lower Airway Hyperreactivity and the Role of Inhalation Therapy

Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.

Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication

Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions linked to Coronavirus profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

It is concluded that the efficient management of issues related to Coronavirus It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: